**Equity Swap Contract**

**General Terms**

This Equity Swap Contract is entered into between Party A (Party1) and Party B (Party2) on the Trade Date of 2021-08-18. The contract is governed by the ISDA Master Agreement and the Confirmation.

**Trade Details**

* Trade Identifier: 33f59567, 33f59568
* Trade Date: 2021-08-18
* Effective Date: 2021-08-18
* Termination Date: 2022-02-18
* Mandatory Early Termination Date: Not applicable

**Trade Product**

* Product Type: Equity Swap
* Product Taxonomy: Equity:Swap:PriceReturnBasicPerformance:SingleName
* Economic Terms:
	+ Effective Date: 2021-08-18
	+ Termination Date: 2022-02-18
	+ Calculation Period Dates: 2021-08-18 to 2022-02-18
	+ Payout:
		- Interest Rate Payout: Party A pays Party B USD SOFR-Compound p.a. on the Notional Amount
		- Performance Payout: Party B pays Party A the difference between the Underlying Price and the Strike Price

**Trade Lot**

* Price Quantity:
	+ Price: 37.44 USD per Share
	+ Quantity: 760400 Shares
	+ Observable: SHPGY.O, Shire Pharmaceuticals Group - American Depositary Receipts
* Settlement Terms: Cash

**Counterparty**

* Party A: Party1
* Party B: Party2

**Ancillary Party**

* Extraordinary Dividends Party: Party1
* Calculation Agent Independent: Party1

**Adjustment**

* Adjustment: Execution

**Party**

* Party A: Party1
* Party B: Party2

**Contract Details**

* Documentation:
	+ Master Agreement: ISDA Master Agreement
	+ Confirmation: ISDA Confirmation
* Governing Law: English
* Documentation: ISDA

**Representations**

* Each party represents to the other party that they are acting for their own account and have made their own independent decisions to enter into this Transaction.

**Risk Disclosure**

* There are significant risks associated with this Transaction, including foreign exchange risk, price risk, liquidity risk, and credit risk.

**Ordinary Course of Business**

* In the ordinary course of their business, Party A or its affiliates may affect transactions for their own account or for the account of their customers.

**Potential Conflicts of Interest**

* Potential conflicts of interest may exist in the structure and operation of the strategy and the course of the normal business activities of Party A or its affiliates.

**Underlying Exposure**

* The purpose of the Equity Swap is to hedge the risk arising out of the underlying exposure of a USD 10,000,000 fixed rate loan maturing on or after 2023-10-05.

**Scenario Analysis**

* The following Scenario Analysis is provided for illustrative and convenience purposes only:
	+ Scenario 1: USD SOFR-Compound remains unchanged over the tenor of the trade
	+ Scenario 2: USD SOFR-Compound increases over the tenor of the trade
	+ Scenario 3: USD SOFR-Compound decreases over the tenor of the trade

**Mark to Market (MTM) Sensitivity Analysis**

* The following MTM Analysis is provided for illustrative and convenience purposes only:
	+ MTM Sensitivity due to parallel shift in USD SOFR-Compound Curve immediately after Trade Date
	+ MTM Sensitivity due to parallel shift in USD SOFR-Compound Curve as on Mandatory Termination Date compared to Trade Date

**Level of Pricing Variables and Impact of Variables on Pricing**

* The following analysis is provided for information and illustrative purposes only:
	+ USD 10 year SOFR-Compound Rate: 4.427%
	+ Primary market variables used for determining the mark-to-market value along with their directional impact

**Periodicity of Valuation Statement from Party A**

* Valuation statements in relation to all Transactions executed between the parties will be made available to the Counterparty on the Optimize application present on JPMorgan's online platform.

**Representations**

* Each party represents to the other party on the date on which it enters into this Transaction that they are acting for their own account and have made their own independent decisions to enter into this Transaction.

Note: This description is a concise summary of the contract details from the provided CDM representation. It does not include unnecessary information from the templates.